An international group of researchers is teaming up to develop a myeloma treatment that harnesses the cancer-killing abilities of natural killer (NK) cells. As…
Myeloma
I stand in the pharmacy aisle holding a packet of painkillers and feel time split in two. In one version, this is just a simple…
More than 40% of patients in a Phase 1 clinical trial of myeloma treatment cevostamab responded to the drug, meaning their cancer burden was…
What do the San Diego Comic-Con and multiple myeloma have in common? Does that sound like a very strange question? Am I still stuck…
Most myeloma patients taking Tecvayli (teclistamab-cqyv) were alive and free from disease progression two years after starting treatment, according to a new analysis…
I keep a ledger that no one else can see. It is not written in the notebook where I record medications and blood test…
A study linked high expression of the protein desmoglein-2 (DSG2) to lower survival in people with myeloma. Data suggest that high DSG2 expression is…
A combination treatment using two Johnson & Johnson immunotherapies outperformed standard care regimens in reducing the risk of disease progression and death among people…
Maintenance therapy for myeloma can be stopped after two years without raising the risk of disease progression or death, a new study shows. “For…
On some afternoons, while my mum and I are at the hospital, I notice how long it takes just to wait for our turn. Whether…
Recent Posts
- Study finds home transfusions safe in hospice care for blood cancer
- Small acts of defiance are the ways we push back against disease
- Under-the-skin myeloma treatment linked to better survival in study
- Add-on therapy shows promise for hard-to-treat AML
- When the caregiver role starts to feel like a second skin